Motley Fool Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.64M | Sell |
6,905
-917
| -12% | -$514K | 0.14% | 111 |
|
|
2026
Q1 | $4.4M | Sell |
7,822
-840
| -10% | -$539K | 0.19% | 103 |
|
|
2025
Q4 | $5.86M | Buy |
8,662
+1,904
| +28% | +$1.3M | 0.23% | 100 |
|
|
2025
Q3 | $4.32M | Buy |
6,758
+1,471
| +28% | +$893K | 0.18% | 110 |
|
|
2025
Q2 | $2.84M | Buy |
5,287
+615
| +13% | +$294K | 0.13% | 124 |
|
|
2025
Q1 | $1.96M | Buy |
4,672
+216
| +5% | +$93.8K | 0.11% | 136 |
|
|
2024
Q4 | $1.84M | Buy |
4,456
+526
| +13% | +$231K | 0.1% | 144 |
|
|
2024
Q3 | $1.95M | Buy |
3,930
+198
| +5% | +$96.2K | 0.12% | 129 |
|
|
2024
Q2 | $1.78M | Buy |
3,732
+808
| +28% | +$406K | 0.12% | 127 |
|
|
2024
Q1 | $1.58M | Buy |
2,924
+359
| +14% | +$196K | 0.1% | 139 |
|
|
2023
Q4 | $1.42M | Buy |
2,565
+150
| +6% | +$70.4K | 0.11% | 129 |
|
|
2023
Q3 | $1.06M | Buy |
2,415
+181
| +8% | +$90.3K | 0.08% | 142 |
|
|
2023
Q2 | $1.12M | Buy |
+2,234
| New | +$1.07M | 0.1% | 133 |
|
|
2023
Q1 | – | Sell |
-2,206
| Closed | -$900K | – | 153 |
|
|
2022
Q4 | $900K | Sell |
2,206
-63
| -3% | -$24.5K | 0.1% | 137 |
|
|
2022
Q3 | $739K | Sell |
2,269
-15
| -0.7% | -$5.51K | 0.07% | 145 |
|
|
2022
Q2 | $838K | Sell |
2,284
-41
| -2% | -$16.7K | 0.08% | 144 |
|
|
2022
Q1 | $1.27M | Buy |
2,325
+122
| +6% | +$64.2K | 0.09% | 129 |
|
|
2021
Q4 | $1.45M | Sell |
2,203
-5
| -0.2% | -$3.14K | 0.09% | 122 |
|
|
2021
Q3 | $1.37M | Buy |
2,208
+175
| +9% | +$118K | 0.09% | 127 |
|
|
2021
Q2 | $1.28M | Buy |
2,033
+13
| +0.6% | +$7.18K | 0.08% | 128 |
|
|
2021
Q1 | $988K | Buy |
2,020
+70
| +4% | +$35.1K | 0.07% | 131 |
|
|
2020
Q4 | $975K | Buy |
1,950
+188
| +11% | +$84.1K | 0.07% | 130 |
|
|
2020
Q3 | $696K | Buy |
1,762
+192
| +12% | +$71K | 0.06% | 137 |
|
|
2020
Q2 | $518K | Sell |
1,570
-17
| -1% | -$4.92K | 0.05% | 136 |
|
|
2020
Q1 | $384K | Buy |
1,587
+92
| +6% | +$24K | 0.05% | 136 |
|
|
2019
Q4 | $390K | Buy |
1,495
+106
| +8% | +$27.9K | 0.04% | 144 |
|
|
2019
Q3 | $378K | Sell |
1,389
-12
| -0.9% | -$3.34K | 0.04% | 150 |
|
|
2019
Q2 | $386K | Buy |
1,401
+24
| +2% | +$5.91K | 0.04% | 152 |
|
|
2019
Q1 | $308K | Buy |
1,377
+267
| +24% | +$55.1K | 0.04% | 154 |
|
|
2018
Q4 | $206K | Sell |
1,110
-8
| -0.7% | -$1.64K | 0.03% | 158 |
|
|
2018
Q3 | $279K | Buy |
+1,118
| New | +$271K | 0.03% | 131 |
|
Other funds holding IDXX
Motley Fool Asset Management's IDXX Position: Q2 2026 in Review
Motley Fool Asset Management reduced its Idexx Laboratories (IDXX) stake by 12% in Q2 2026, selling an estimated $514K and leaving 6,905 shares worth $3.64M. The position accounts for 0.14% of the portfolio, ranked #111.
Motley Fool Asset Management first reported a position in IDXX in Q3 2018 and has held it in 31 quarters since. The position peaked at $5.86M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Motley Fool Asset Management held 6,905 shares of Idexx Laboratories worth $3.64M as of Q2 2026.
- Motley Fool Asset Management sold 917 Idexx Laboratories shares in Q2 2026, an estimated $514K.
- Idexx Laboratories made up 0.14% of Motley Fool Asset Management's portfolio in Q2 2026, its #111 holding.
- Motley Fool Asset Management first reported a position in Idexx Laboratories in Q3 2018 and has held it in 31 quarters since.
- Motley Fool Asset Management's Idexx Laboratories position peaked at $5.86M in Q4 2025.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Motley Fool Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.